Folgen
Sathya Venkataramani
Sathya Venkataramani
Bestätigte E-Mail-Adresse bei boehringer-ingelheim.com
Titel
Zitiert von
Zitiert von
Jahr
Thermal stability of high concentration lysozyme across varying pH: A Fourier Transform Infrared study
S Venkataramani, J Truntzer, DR Coleman
Journal of pharmacy and bioallied sciences 5 (2), 148-153, 2013
1352013
Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia
RP Adhikari, H Karauzum, J Sarwar, L Abaandou, M Mahmoudieh, ...
PloS one 7 (6), e38567, 2012
1252012
Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome
H Karauzum, G Chen, L Abaandou, M Mahmoudieh, AR Boroun, ...
Journal of Biological Chemistry 287 (30), 25203-25215, 2012
742012
Folding of a designed simple ankyrin repeat protein
VS Devi, HK Binz, MT Stumpp, A Plückthun, HR Bosshard, I Jelesarov
Protein Science 13 (11), 2864-2870, 2004
552004
Biophysical techniques for characterizing the higher order structure and interactions of monoclonal antibodies
Y Gokarn, S Agarwal, K Arthur, A Bepperling, ES Day, D Filoti, DG Greene, ...
State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal …, 2015
422015
Design and characterization of Zweimab and Doppelmab, high affinity dual antagonistic anti-TSLP/IL13 bispecific antibodies
S Venkataramani, S Low, B Weigle, D Dutcher, K Jerath, M Menzenski, ...
Biochemical and biophysical research communications 504 (1), 19-24, 2018
382018
Thermal unfolding curves of high concentration bovine IgG measured by FTIR spectroscopy
V Sathya Devi, DR Coleman, J Truntzer
The Protein Journal 30 (6), 395-403, 2011
302011
Unexpected Potency Differences between B-Cell–Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound
AM Nicoletti, CH Kenny, AM Khalil, Q Pan, KLM Ralph, J Ritchie, ...
Journal of Pharmacology and Experimental Therapeutics 359 (1), 37-44, 2016
202016
Disulfide formation and stability of a cysteine-rich repeat protein from Helicobacter pylori
VS Devi, CB Sprecher, P Hunziker, PRE Mittl, HR Bosshard, I Jelesarov
Biochemistry 45 (6), 1599-1607, 2006
192006
Dominant effect of ethanol in thermal destabilization of bovine serum albumin in the presence of sucrose
V Sathya Devi, OO Chidi, D Coleman
Spectroscopy 23 (5-6), 265-270, 2009
122009
Monitoring the Disulfide Bond Formation of a Cysteine-Rich Repeat Protein from Helicobacter pylori in the Periplasm of Escherichia coli
VS Devi, PRE Mittl
Current microbiology 62, 903-907, 2011
82011
Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides
MJ Aman, RP Adhikari, H Karauzum, J Sarwar, S Shulenin, ...
US Patent 10,023,848, 2018
52018
Anti-TrkB antibodies
R Herrmann, RA Bakker, S Bandholtz, PM Benz, M Dziegelewski, L Florin, ...
US Patent 10,793,634, 2020
22020
Anti-TrkB antibodies
R Herrmann, RA Bakker, S Bandholtz, PM Benz, M Dziegelewski, ...
US Patent 11,866,501, 2024
2024
Monospecific and multispecific anti-TMEFF2 antibodies and their uses
P Cooper, R Ernst, R Ganesan, C Kane, M Russell, S Singh, ...
US Patent 11,866,499, 2024
2024
Anti-sema3a antibodies and their uses for treating eye or ocular diseases
L Thomas, RR Barrett, KL Bovat, R Ganesan, P Gupta, F Han, D Liu, ...
US Patent 11,267,880, 2022
2022
Imunogeni sastav koji sadrži polipeptide izvedene iz panton-valentin leukocidina (pvl)
MJ Aman, RP Adhikari, H Karauzum, J Sarwar, S Shulenin, ...
2019
Imunogeninė kompozicija, apimanti polipeptidus, kilusius iš pantono-valentino leukocidino (pvl)
MJ Aman, RP ADHIKARI, H KARAUZUM, J Sarwar, S Shulenin, ...
2019
Immunogen sammensætning, der omfatter panton-valentine-leukocidin (pvl)-afledte polypeptider
MJ Aman, RP Adhikari, H Karauzum, J Sarwar, S Shulenin, ...
2019
Immunogenic composition comprising panton-valentine leukocidin (pvl) derived polypeptides
MJ Aman, RP ADHIKARI, H KARAUZUM, J Sarwar, S Shulenin, ...
2013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20